The Endoplasmic Reticulum Chaperone GRP78/BiP Modulates Prion Propagation in vitro and in vivo

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Park, Kyung Won ^a   Eun Kim, Gyoung ^b   Morales, Rodrigo ^a   Moda, Fabio ^a   Moreno Gonzalez, Ines ^a   Concha Marambio, Luis ^a,c   Lee, Amy S ^d   Hetz, Claudio ^e,f,g,h   Soto, Claudio ^a,c  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSIDAD DE LOS ANDES   (Chile)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF CHILE   (Chile)

^f Universidad de Chile and Geroscience Center for Brain Health and Metabolism   (Chile)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^h BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN; MOLECULAR CHAPERONE GRP78; PEPTIDE HYDROLASE; PRION PROTEIN; PROTEIN BINDING;

ANIMAL; C57BL MOUSE; CELL FREE SYSTEM; CELL LINE; CELL VACUOLE; ENDOPLASMIC RETICULUM; METABOLISM; PRION; PRION DISEASE;

ANIMALS; CELL LINE; CELL-FREE SYSTEM; ENDOPLASMIC RETICULUM; HEAT-SHOCK PROTEINS; MICE, INBRED C57BL; PEPTIDE HYDROLASES; PRION DISEASES; PRIONS; PROTEIN BINDING; PRPSC PROTEINS; VACUOLES;

EID: 85016158513     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep44723     Document Type: Article

References (56)

1. Prusiner, S. B. Prions. Proc. Natl. Acad. Sci. USA 95, 13363-13383 (1998).
2. Soto, C. & Saborio, G. P. Prions: disease propagation and disease therapy by conformational transmission. Trends Mol. Med. 7, 109-114 (2001).
3. Hetz, C. A. & Soto, C. Stressing Out the ER: A Role of the Unfolded Protein Response in Prion-Related Disorders. 6, 37-43 (2006).
4. Halliday, M. & Mallucci, G. R. Targeting the unfolded protein response in neurodegeneration: A new approach to therapy. 76 Pt A, 169-174 (2014).
5. Malhotra, J. D. & Kaufman, R. J. The endoplasmic reticulum and the unfolded protein response. Semin. Cell Dev. Biol. 18, 716-731 (2007).
6. Kim, I., Xu, W. & Reed, J. C. Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat. Rev. Drug Discov. 7, 1013-1030 (2008).
7. Hetz, C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat. Rev. Mol. Cell Biol. 13, 89-102 (2012).
8. Hetz, C. et al. Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. EMBO J. 22, 5435-5445 (2003).
9. Moreno, J. A. et al. Sustained translational repression by eIF2alpha-P mediates prion neurodegeneration. Nature 485, 507-511 (2012).
10. Mukherjee, A. & Soto, C. Role of calcineurin in neurodegeneration produced by misfolded proteins and endoplasmic reticulum stress. Curr. Opin. Cell Biol. 23, 223-230 (2011).
11. Hetz, C. & Mollereau, B. Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases. Nat. Rev. Neurosci. 15, 233-249 (2014).
12. Ni, M. & Lee, A. S. ER chaperones in mammalian development and human diseases. FEBS Lett. 581, 3641-3651 (2007).
13. Lee, A. S. The glucose-regulated proteins: stress induction and clinical applications. Trends Biochem. Sci. 26, 504-510 (2001).
14. Hendershot, L. M. The ER function BiP is a master regulator of ER function. Mt. Sinai J. Med. 71, 289-297 (2004).
15. Jin, T. et al. The chaperone protein BiP binds to a mutant prion protein and mediates its degradation by the proteasome. J. Biol. Chem. 275, 38699-38704 (2000).
16. Morris, J. A. et al. Immunoglobulin binding protein (BiP) function is required to protect cells from endoplasmic reticulum stress but is not required for the secretion of selective proteins. J. Biol. Chem. 272, 4327-4334 (1997).
17. Ni, M., Zhang, Y. & Lee, A. S. Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signalling and therapeutic targeting. Biochem. J. 434, 181-188 (2011).
18. Wang, M. et al. Role of the unfolded protein response regulator GRP78/BiP in development, cancer, and neurological disorders. Antioxid. Redox. Signal. 11, 2307-2316 (2009).
19. Lee, A. S. Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential. Nat. Rev. Cancer 14, 263-276 (2014).
20. Torres, M. et al. Prion protein misfolding affects calcium homeostasis and sensitizes cells to endoplasmic reticulum stress. PLoS One. 5, e15658 (2010).
21. Hetz, C. et al. The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity. J. Neurosci. 25, 2793-2802 (2005).
22. Luo, S. et al. GRP78/BiP is required for cell proliferation and protecting the inner cell mass from apoptosis during early mouse embryonic development. Mol. Cell Biol. 26, 5688-5697 (2006).
23. Dong, D. et al. Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development. Cancer Res. 68, 498-505 (2008).
24. Fraser, H. & Dickinson, A. G. The sequential development of the brain lesion of scrapie in three strains of mice. J. Comp Pathol. 78, 301-311 (1968).
25. Moda, F. et al. Brain delivery of AAV9 expressing an anti-PrP monovalent antibody delays prion disease in mice. Prion. 6, 383-390 (2012).
26. Moreno, J. A. et al. Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice. Sci. Transl. Med. 5, 206ra138 (2013).
27. Mahal, S. P. et al. Prion strain discrimination in cell culture: the cell panel assay. Proc. Natl. Acad. Sci. USA 104, 20908-20913 (2007).
28. Moore, K. A. & Hollien, J. The unfolded protein response in secretory cell function. Annu. Rev. Genet. 46, 165-183 (2012).
29. Moreno-Gonzalez, I. & Soto, C. Misfolded protein aggregates: mechanisms, structures and potential for disease transmission. Semin. Cell Dev. Biol. 22, 482-487 (2011).
30. Soto, C. Transmissible Proteins: Expanding the Prion Heresy. Cell 149, 968-977 (2012).
31. Torres, M. et al. Abnormal calcium homeostasis and protein folding stress at the ER: A common factor in familial and infectious prion disorders. Commun. Integr. Biol. 4, 258-261 (2011).
32. Wang, M. et al. Essential role of the unfolded protein response regulator GRP78/BiP in protection from neuronal apoptosis. Cell Death. Differ. 17, 488-498 (2010).
33. Jin, H. et al. Late-onset of spinal neurodegeneration in knock-in mice expressing a mutant BiP. PLoS One. 9, e112837 (2014).
34. Yamagishi, N. et al. Endoplasmic reticulum chaperone GRP78 suppresses the aggregation of proteins containing expanded polyglutamine tract. Biochem. Biophys. Res. Commun. 422, 527-533 (2012).
35. Nakanishi, T. et al. Role of endoplasmic reticulum stress in light-induced photoreceptor degeneration in mice. J. Neurochem. 125, 111-124 (2013).
36. Zhao, L. et al. Protein accumulation and neurodegeneration in the woozy mutant mouse is caused by disruption of SIL1, a cochaperone of BiP. Nat. Genet. 37, 974-979 (2005).
37. Filezac de, L. E. et al. Marinesco-Sjogren syndrome protein SIL1 regulates motor neuron subtype-selective ER stress in ALS. Nat. Neurosci. 18, 227-238 (2015).
38. Rao, R. V. et al. Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78. FEBS Lett. 514, 122-128 (2002).
39. Reddy, R. K. et al. Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors - Role of ATP binding site in suppression of caspase-7 activation. J. Biol. Chem. 278, 20915-20924 (2003).
40. Zhou, H. et al. Novel mechanism of anti-apoptotic function of 78-kDa glucose-regulated protein (GRP78): endocrine resistance factor in breast cancer, through release of B-cell lymphoma 2 (BCL-2) from BCL-2-interacting killer (BIK). J. Biol. Chem. 286, 25687-25696 (2011).
41. Yoo, B. C. et al. Overexpressed protein disulfide isomerase in brains of patients with sporadic Creutzfeldt-Jakob disease. Neurosci. Lett. 334, 196-200 (2002).
42. Torres, M. et al. The Protein Disulfide Isomerase ERp57 Regulates the Steady-State Levels of the Prion Protein. J. Biol. Chem. (2015).
43. Hetz, C. et al. Unfolded protein response transcription factor XBP-1 does not influence prion replication or pathogenesis. Proc. Natl. Acad. Sci. USA 105, 757-762 (2008).
44. Steele, A. D. et al. Prion pathogenesis is independent of caspase-12. 1, 243-247 (2007).
45. Gorbatyuk, M. S. et al. Glucose regulated protein 78 diminishes alpha-synuclein neurotoxicity in a rat model of Parkinson disease. Mol. Ther. 20, 1327-1337 (2012).
46. Gorbatyuk, M. S. & Gorbatyuk, O. S. The Molecular Chaperone GRP78/BiP as a Therapeutic Target for Neurodegenerative Disorders: A Mini Review. J. Genet. Syndr. Gene Ther. 4 (2013).
47. Baumeister, P. et al. Transcriptional induction of GRP78/BiP by histone deacetylase inhibitors and resistance to histone deacetylase inhibitor-induced apoptosis. Mol. Cancer Ther. 8, 1086-1094 (2009).
48. Kudo, T. et al. A molecular chaperone inducer protects neurons from ER stress. Cell Death. Differ. 15, 364-375 (2008).
49. Oida, Y. et al. Induction of BiP, an ER-resident protein, prevents the neuronal death induced by transient forebrain ischemia in gerbil. Brain Res. 1208, 217-224 (2008).
50. Inokuchi, Y. et al. Effect of an inducer of BiP, a molecular chaperone, on endoplasmic reticulum (ER) stress-induced retinal cell death. Invest Ophthalmol. Vis. Sci. 50, 334-344 (2009).
51. Hetz, C., Chevet, E. & Harding, H. P. Targeting the unfolded protein response in disease. Nat. Rev. Drug Discov. 12, 703-719 (2013).
52. Castilla, J. et al. Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions. Cell 134, 757-768 (2008).
53. Abid, K., Morales, R. & Soto, C. Cellular factors implicated in prion replication. FEBS Lett. 584, 2409-2414 (2010).
54. Urayama, A. et al. Initial fate of prions upon peripheral infection: half-life, distribution, clearance, and tissue uptake. FASEB J. 25, 2792-2803 (2011).
55. Morales, R. et al. Lack of prion transmission by sexual or parental routes in experimentally infected hamsters. Prion. 7, 412-419 (2013).
56. Jozefczuk, J., Drews, K. & Adjaye, J. Preparation of mouse embryonic fibroblast cells suitable for culturing human embryonic and induced pluripotent stem cells. J. Vis. Exp. (2012).